About PURAPHARM Company

The Group is a Hong Kong Chinese medicine company leading the concentrated Chinese medicine formula granule market. Under its “Nongbenfang” brand, the Group is engaged in R&D, production, marketing and sales of concentrated Chinese medicine formula granule products. The Group is one of only five overseas enterprises in China that have obtained approval from the Drug Administration to manufacture and sell concentrated Chinese medicine formula granular products in China. In addition, the Group is a national standard laboratory certified by CNAS according to ISO17025, and the Group's test reports have been recognized by more than 70 countries around the world. Since 2004, the Group has been supplying concentrated Chinese medicine formula granular products to most hospitals and traditional Chinese medicine clinics in Hong Kong. Currently, the Group has secured its leading position in the Hong Kong concentrated Chinese medicine formula granular products market. It is the largest supplier, and is also the leading Chinese medicine clinic chain in Hong Kong. Since its establishment in 1998, the Group has been committed to the modernization and internationalization of traditional Chinese medicine, and has actively cooperated with many internationally renowned scholars and scientific research institutions, and has long established a position as a technological pioneer in the traditional Chinese medicine market. Through continuous innovation, the Group has been hailed as a leader in the industry in research and development, production, marketing and sales of traditional Chinese medicines, quality control, and basic scientific research. The Group has established its own traditional Chinese medicine research and production base in Nanning, Guangxi, China. The production facilities not only meet China's GMP standards, but also meet the Australian TGA standard, which is one of the strictest international standard certifications, and the PIC/S pharmaceutical standards of the International Pharmaceutical Inspection Organization. The Group is also the only manufacturer of its concentrated Chinese medicine formula granular products certified and approved by the United States Pharmacopeia (USP). The Group's own national standard laboratory has obtained CNAS certification according to ISO17025. This is an international multilateral mutual recognition system, making the Group one of the most advanced traditional Chinese medicine research and production facilities in Asia. With advanced development concepts and production technology, a series of non-prescription health products developed by the Group, such as famous brands such as Ganoderma lucidum, Angelica, Antioxidant, and Ufa Nong, are popular in Hong Kong and overseas markets. Our company advantages The Group is a market leader in concentrated Chinese medicine formula granular products in Hong Kong. Our products are also widely recognized as high quality, reliable and safe. The Group has a complete range of single and compound concentrated traditional Chinese medicine formula granular products, and provides a unique patented “Intelligent Traditional Chinese Medicine Clinic Management and Dispensing System” to provide traditional Chinese medicine customers and users with a complete and modern solution combining traditional Chinese medicine diagnosis, dispensing and clinic management. The Group's modern production equipment, strong scientific research strength, and strict drug safety testing and quality control enable us to ensure the high quality and safety of our products throughout the production process. The Group is a pioneer in the modernization and internationalization of traditional Chinese medicine research and development. With our successful experience in developing traditional Chinese medicine products, especially our impressive achievements in concentrated traditional Chinese medicine formula granular compound products, we are ahead of our peers and stand out. In order to enhance the Group's R&D capabilities, the Group built a new R&D center with a total construction area of 1,632 square meters in Nanning to develop innovative products and prepare for the upcoming standardization of concentrated Chinese medicine formula granules in China. Advanced production facilities One of the best Chinese medicine facilities in Asia The Group's own traditional Chinese medicine production base is located in Nanning High-tech Development Zone, Guangxi Zhuang Autonomous Region. It covers an area of about 17,241 square meters, with a total construction area of about 7,760 square meters. From the design of the production base to the advanced processes and testing technology used throughout the production process of traditional Chinese medicine, everything is carefully designed by the Group. The Group's plant was built with the help of construction, engineering, pharmaceutical and equipment experts from Canada, Australia and Japan. The entire production line and process not only complies with internal standard operating procedures, but is also certified by Chinese GMP standards, Australian TGA standards, and PIC/S and USP standards of the International Pharmaceutical Inspection Agreement. It can be called one of the most advanced, precise, and well-managed traditional Chinese medicine research and production facilities in Asia. The Group uses highly automated production facilities and is controlled by a central computer system. Production equipment includes high-efficiency dynamic liquid phase extractors, low temperature concentration equipment, large-scale instantaneous spray drying systems, and equipment used for freeze-drying, vacuum drying, and fluidized bed drying of Chinese herbal medicine extracts. The entire pellet production process is carried out in clean rooms that meet relevant GMP standards. New smart factory in Nanning The Group is developing and constructing a new smart factory in the Nanning High-tech Development Zone in Guangxi Zhuang Autonomous Region, covering an area of about 49,185 square meters, with a total construction area of about 65,967.66 square meters. The smart factory will be a leap from traditional automation to a fully interconnected and flexible system. It can use the constant data flow of interconnected operations and production systems to learn and adapt to future needs. The first phase of the project (consisting of 3 modern warehouse buildings) was completed at the end of 2020 (total construction area: 25,079 square meters) and will become a central hub for product supply. Japan pilot plant SODX, a Japanese subsidiary of the Group, has a pilot plant located in Osaka, Japan, which has obtained health food GMP certification, with a total construction area of about 1,460 square meters. The plant is equipped with high-tech production machines to enable SODX to produce health foods with different packaging and dosage, such as granules, tablets, capsules, etc., to meet the specific needs of customers. The pilot plant will also be used as a new product development center for the Group to further expand its business. SODX's best-selling products include antioxidants, fermented health foods, and health foods developed with propolis. US GMP factory The Group provides more than 300 kinds of rich herbal formula products under the “KAN” brand in the US and European markets through its subsidiary Kan Herb Company in California. KanHerb is meticulous about the efficiency, quality and safety of each proprietary product, and manufactures “KAN” products in California in accordance with GMP. From purchasing and testing raw materials to manufacturing and packaging products, KanHerb controls every stage of the production process. We demonstrate superior quality through innovative technology, production of the highest percentage of active herbal ingredients per ounce, optimized customer service, and professional consulting.